Technology | March 15, 2013

Activation Imaging Technology Improves Treatment of CRT for Better Patient Outcomes, Lower Costs

Toshiba’s new offering enhances cardiac function assessment

Toshiba echo activation image showing a color-coded map of where activation starts and ends during each contraction. This example shows a posterior lateral infarction timing defect.

An activation imaging example showing a heart with left bundle branch block. Its believed this type of imaging will help lead to better CRT lead placement optimization.

March 15, 2013 – For better treatment planning during cardiac resynchronization therapy (CRT), Toshiba America Medical System Inc.’s Activation Imaging is the company’s latest addition to its 3-D Wall Motion Tracking software. Activation Imaging is an U.S. Food and Drug Administration (FDA)-cleared, proprietary technology available on the Aplio Artida cardiovascular ultrasound system.

When the heart is not functioning properly, different segments activate at different moments in time. Activation Imaging, in conjunction with Toshiba’s comprehensive 3-D Wall Motion Tracking software, allows clinicians to evaluate dyssynchrony at the onset of the heart’s contraction and to properly identify the left ventricle’s pumping strength and timing for more accurate lead placements in CRT treatment.

“Toshiba continues to pioneer innovative ultrasound technology to improve patient outcomes,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Studies show that CRT procedures have a 33 percent failure rate.[1] Activation Imaging’s ability to measure dyssynchrony at a more appropriate moment in time, the onset of contraction, will provide greater confidence during CRT planning to improve patient outcomes and lower healthcare costs.”

Toshiba showcased Activation Imaging at this year’s American College of Cardiology (ACC) annual meeting in San Francisco, March 9 to 11.

For more information: www.medical.toshiba.com

1. Abraham WT, Fisher WG, Smith AL, et al. “MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure.” N Engl J Med 2002;346: 1845–53.

Related Content

Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
Epsilon Imaging Demonstrates Strain Imaging Integration for Echo Programs at ASE 2018
News | Cardiovascular Ultrasound | June 19, 2018
Clinical practice, along with guidelines and research, have shown that speckle tracking strain imaging can improve...
FDA Clears Bay Labs' EchoMD AutoEF Software for AI Echo Analysis
Technology | Cardiovascular Ultrasound | June 19, 2018
Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(...
Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program
News | Prostate Cancer | June 14, 2018
Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part of the RAPID...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Olympus and Hitachi Healthcare Americas Introduce Arietta 850
News | Ultrasound Imaging | June 04, 2018
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedu
New Ultrasound Guidelines Reliably Identify Children Who Should be Biopsied for Thyroid Cancer

Image courtesy of Loyola Medicine

News | Pediatric Imaging | May 29, 2018
A Loyola Medicine study has found that new ultrasound guidelines can reliably identify pediatric patients who should be...
Samsung Receives FDA Clearance for Premium Ultrasound System RS85
Technology | Ultrasound Imaging | May 07, 2018
NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced the Samsung RS85 ultrasound system has received U....
3D-4D ultrasound of a fetus imaged with a GE Volusion E10 system. It shows the yoke sac. This is a baby ultrasound, also referred to as fetal ultrasound or prenatal ultrasound.

3D-4D ultrasound of a fetus imaged with a GE Volusion E10 system. It shows the yoke sac.

Feature | Ultrasound Women's Health | May 07, 2018
Below is a collection of prenatal ultrasound images from the ITN archive.
Esaote Change of Ownership Completed
News | Ultrasound Imaging | April 30, 2018
The acquisition of biomedical equipment company Esaote SpA’s share capital was completed on April 19, the company...
Overlay Init